Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 45

Tests names and labsConditionsGenes and analytesMethods

PharmacoScan

RPRD Diagnostics, LLC
United States
3511
  • T Targeted variant analysis

OneOme RightMed pharmacogenomic test

OneOme
United States
9421
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Coumarin/Warfarin resistance due to CYP2C9 variants

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Warfarin sensitivity

Genomic Engenharia Molecular
Brazil
12
  • T Targeted variant analysis

Coumarin resistance

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Warfarin Sensitivity, CYP2C9 and VKORC1, 3 Mutations

ARUP Laboratories, Molecular Genetics and Genomics
United States
12
  • T Targeted variant analysis

Warfarin response

Xcode Life
India
12
  • T Targeted variant analysis

Rxight Pharmacogenetics Program

MD Labs
United States
7920
  • A Analyte

Warfarin Panel

Castle Medical Molecular Diagnostics Castle Medical, LLC
United States
15
  • T Targeted variant analysis

Genetic Study of Warfarin Pharmacogenetics

HeartGenetics, Genetics and Biotechnology, SA
Portugal
12
  • T Targeted variant analysis

Cytochrome P450 2C9, CYP2C9 - 2 Variants

ARUP Laboratories, Molecular Genetics and Genomics
United States
11
  • T Targeted variant analysis

CYP2C9 (diabetes, thrombosis and other treatments)

Laboratorio de Genetica Clinica SL
Spain
11
  • C Sequence analysis of the entire coding region

Warfarin resistance (sequence analysis of VKORC1 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Warfarin resistance (sequence analysis of VKORC1 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Warfarin Sensitivity

True Health Diagnostics
United States
12
  • T Targeted variant analysis

Susceptibility to Drugs , Sequencing CYP2C9 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Warfarin response

Labor Dr. Wisplinghoff
Germany
11
  • C Sequence analysis of the entire coding region

CYP2C9 genotyping

Alpha Genomix Laboratories
United States
41
  • T Targeted variant analysis

VKORC1 genotyping

Alpha Genomix Laboratories
United States
21
  • T Targeted variant analysis

VKORC1

Millennium Health
United States
11
  • T Targeted variant analysis

Results: 1 to 20 of 45

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center